Your browser doesn't support javascript.
loading
Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study.
Yang, Chao; Jiang, Min; Wang, Xiaohui; Tang, Xiujuan; Fang, Shisong; Li, Hao; Zuo, Le; Jiang, Yixiang; Zhong, Yifan; Chen, Qiongcheng; Zheng, Chenli; Wang, Lei; Wu, Shuang; Wu, Weihua; Liu, Hui; Yuan, Jing; Liao, Xuejiao; Zhang, Zhen; Shi, Xiaolu; Geng, Yijie; Zhang, Huan; Zheng, Huanying; Wan, Min; Lu, Linying; Ren, Xiaohu; Cui, Yujun; Zou, Xuan; Feng, Tiejian; Xia, Junjie; Yang, Ruifu; Liu, Yingxia; Mei, Shujiang; Li, Baisheng; Yang, Zhengrong; Hu, Qinghua.
Afiliación
  • Yang C; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Jiang M; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Wang X; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Tang X; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Fang S; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Li H; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Zuo L; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Jiang Y; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Zhong Y; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Chen Q; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Zheng C; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Wang L; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Wu S; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Wu W; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Liu H; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Yuan J; State Key Discipline of Infectious Disease, National Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Liao X; State Key Discipline of Infectious Disease, National Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Zhang Z; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Shi X; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Geng Y; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Zhang H; Guangdong Provincial Center for Disease Control and Prevention, Guangdong, People's Republic of China.
  • Zheng H; Guangdong Provincial Center for Disease Control and Prevention, Guangdong, People's Republic of China.
  • Wan M; Shenzhen LongHua District Maternity and Child Healthcare Hospital, Shenzhen, People's Republic of China.
  • Lu L; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Ren X; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Cui Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.
  • Zou X; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Feng T; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Xia J; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Yang R; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.
  • Liu Y; State Key Discipline of Infectious Disease, National Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People's Republic of China.
  • Mei S; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Li B; Guangdong Provincial Center for Disease Control and Prevention, Guangdong, People's Republic of China.
  • Yang Z; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
  • Hu Q; Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
Emerg Microbes Infect ; 9(1): 2368-2378, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33151135
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía Viral / ARN Viral / Infecciones por Coronavirus / Técnicas de Laboratorio Clínico / Anticuerpos Neutralizantes / Betacoronavirus / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Emerg Microbes Infect Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía Viral / ARN Viral / Infecciones por Coronavirus / Técnicas de Laboratorio Clínico / Anticuerpos Neutralizantes / Betacoronavirus / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Emerg Microbes Infect Año: 2020 Tipo del documento: Article